Government's reponse to the deferring of medicines on the PBS

Parliament house flag post

Government's reponse to the deferring of medicines on the PBS

Posted 30/09/2011 by Rebecca de Boer

The announcement by the Government earlier today that medicines previously deferred on the Pharmaceutical Benefits Scheme (PBS) will be listed on the PBS has been welcomed by the main stakeholder groups. Medicines Australia (MA), the Consumers Health Forum (CHF) and the Generic Medicines Industry Association (GMiA) have all been lobbying Government to reverse the deferral decision made in February this year. See here and here for background.

At the same time, the Government also released the ‘statement of principles of commitment between stakeholders.’ This sets out the short and medium term arrangements for the deferral of PBS medicines.

In short, between now and October 2012, medicines approved by the Pharmaceutical Benefits Advisory Committee (PBAC) that cost less than $10 million per year (in each year of the Forward Estimates) will not be delayed listing on the PBS. MA, CHF, and GMiA have also committed to ‘discuss’ with Government ways in which future deferrals can be managed and identify possible savings to the PBS in the next Budget. In addition, MA, CHF and GMiA will also present the Government with a paper canvassing additional savings that could be achieved by Government when the Memorandum of Understanding (MOU) with MA expires in 2014.

While this announcement has the broad support of stakeholders, there are many questions left unanswered. For example:

  • The Government’s media release indicated that ‘budget savings created by price reductions’ had enabled the listing of these deferred medicines. This represents a subtle shift from the accepted practice of listing PBS medicines, that is, medicines were listed on the PBS if they met the legislative criteria. The PBS is an uncapped program, designed to provide access to a wide range of prescription pharmaceuticals to all Australians. It is one of the few publicly funded programs with an explicit requirement for an economic evaluation (assessment of ‘value for money’) before receiving government subsidy. This raises questions about the role of economic evaluation when the Government makes decisions about PBS expenditure as well as broader questions about the listing of medicines on the PBS.
  • It is not possible to verify whether, or how, these particular savings have been made. There is no public reporting on how the saving expected from the MOU and the initial 2007 PBS reform measures are achieved. The Report to the Parliament on the impact of the 2007 PBS reforms revealed that the savings anticipated from these measures have been revised down from $580 million to $103 million over four years but it is not known whether these savings have been achieved. It is important to note that there is no requirement in the MOU which binds MA to deliver the anticipated savings to Government.
  • The statement does not explain what will happen to the listing of drugs that cost more than $10 million per year. Will these medicines continue to be considered by Cabinet? Previously, medicines that were expected to cost more than $10 million in any of the first four years of PBS listing had to be considered by Cabinet before they could be listed. Will the listing of these medicines now be deferred until 2012 or ‘until circumstances permit’ (as applied to medicines that were deferred in February)?
  • As part of the listing process on the PBS, the PBAC makes an assessment of the clinical and cost-effectiveness of the pharmaceutical. Only products that receive a positive recommendation can be listed on the PBS (subject to Ministerial approval). The Guidelines for listing products on the PBS note that there is no ‘threshold’ for cost-effectiveness which determines a positive recommendation. By guaranteeing that medicines costing less than $10 million per annum over the Forward Estimates (and with a positive recommendation from the PBAC) will be listed, it could be argued that the Government is introducing a de-facto financial threshold for the listing of medicines on the PBS. While the result of such a threshold may be to encourage some pharmaceutical manufacturers to lower their price to government, it may also encourage others to restrict the availability of their medicine to certain populations so this de-facto threshold might be met. If this occurred it could raise questions about whether patients are able to access the most appropriate drug for their clinical need.

Today’s announcement gives the Government another year to determine the best way to deal with the listing of high cost drugs on the PBS. The Government has also committed to engaging with MA, CHF and GMiA to develop future policy options for savings on the cost of the PBS. Given the differing concerns of each of these groups, balancing their competing objectives will be no mean feat, especially if savings are to be achieved. There is no shortage of ideas for savings from the PBS (see here and here and here) but there is no consensus about the best approach. It remains to be seen whether pharmaceutical policy stakeholders will continue their united front when putting forward options to Government. For the Government, the ongoing challenge of balancing access and affordability to PBS medicines remains.


Thank you for your comment. If it does not require moderation, it will appear shortly.
Facebook LinkedIn Twitter Add | Email Print

FlagPost

Flagpost is a blog on current issues of interest to members of the Australian Parliament


Parliamentary Library Logo showing Information Analysis & Advice

Archive

Syndication

Tagcloud

refugees asylum immigration Australian foreign policy Parliament climate change elections women social security Indigenous Australians Australian Bureau of Statistics Employment Sport illicit drugs people trafficking taxation Medicare welfare reform Australian Defence Force higher education welfare policy United Nations health financing Asia income management Middle East criminal law disability Australian Sports Anti-Doping Agency World Anti-Doping Agency United States federal budget gambling school education forced labour aid statistics Australian Electoral Commission WADA emissions trading dental health Australia in the Asian Century steroids detention Private health insurance OECD ASADA labour force transport Law Enforcement Australian Federal Police Industrial Relations people smuggling National Disability Insurance Scheme Australian Crime Commission slavery Senate election results Papua New Guinea Australian Public Service constitution International Women's Day corruption Afghanistan Fair Work Act child protection debt federal election 2013 parliamentary procedure poker machines ALP New Zealand Newstart Parenting Payment 43rd Parliament political parties Census High Court skilled migration voting Federal Court terrorist groups Higher Education Loan Program HECS youth paid parental leave Aviation environment foreign debt gross debt net debt defence capability customs doping health crime health risks multiculturalism aged care Gonski Review of Funding for Schooling sex slavery sea farers Special Rapporteur leadership United Kingdom UK Parliament Electoral reform politics banking firearms public policy violence against women domestic violence mental health China ADRV terrorism social media pensions welfare ASIO intelligence community Australian Security Intelligence Organisation governance public service reform Carbon Pricing Mechanism carbon tax mining military history employer employee fishing by-election European Union same sex relationships international relations coal seam gas family assistance planning United Nations Security Council Australian economy food vocational education and training Drugs health reform Indonesia children codes of conduct terrorist financing health system money laundering asylum seekers early childhood education Canada Population Financial sector national security fuel disability employment Tasmania integrity science research and development Australian Secret Intelligence Service sexual abuse federal state relations World Trade Organization Australia accountability housing affordability bulk billing water renewable energy children's health health policy Governor-General US economy export liquefied natural gas foreign bribery question time speaker superannuation expertise Senators and Members climate Intergovernmental Panel on Climate Change Department of Agriculture Fisheries and Forestry food labelling Pacific Islands reserved seats new psychoactive substances synthetic drugs UNODC carbon markets Indigenous constitutional recognition of local government local government consumer laws PISA royal commission US politics language education baby bonus Leaders of the Opposition Parliamentary remuneration Australia Greens servitude Trafficking Protocol energy forced marriage rural and regional Northern Territory Emergency Response ministries social citizenship human rights High Court; Indigenous; Indigenous Australians; Native Title ACT Indigenous education Norfolk Island External Territories emissions reduction fund; climate change child care funding refugees immigration asylum procurement Indigenous health e-voting internet voting nsw state elections 44th Parliament 2015 ABS Age Pension Death penalty capital punishment execution Bali nine Bali bombings Trade EU China soft power education Fiji India Disability Support Pension Antarctica Diplomacy by-elections state and territories workers Bills anti-corruption fraud bribery transparency corporate ownership whistleblower G20 economic reform innovation standards NATO Members of Parliament Scottish referendum Middle East; national security; terrorism social services Criminal Code Amendment (Misrepresentation of Age to a Minor) Bill 2013 online grooming sexual assault of minors ACT Assembly public health smoking plain packaging tobacco cigarettes Asia; Japan; international relations Work Health and Safety Migration; asylum seekers; regional processing China; United States; international relations fiscal policy Racial Discrimination Act; social policy; human rights; indigenous Australians Foreign policy Southeast Asia Israel Palestine regional unemployment asylum refugees immigration political finance donations foreign aid Economics efficiency productivity human rights; Racial Discrimination Act employment law bullying Animal law; food copyright Australian Law Reform Commission industry peace keeping contracts workplace policies trade unions same-sex marriage disorderly conduct retirement Parliament House standing orders public housing prime ministers election timetable sitting days First speech defence budget submarines Somalia GDP forestry world heritage political engagement leave loading Trade; tariffs; safeguards; Anti-dumping public interest disclosure whistleblowing Productivity Commission regulation limitation period universities Ireland cancer gene patents genetic testing suspension of standing and sessional orders animal health live exports welfare systems infant mortality middle class welfare honorary citizen railways disciplinary tribunals standard of proof World Health Organisation arts international students skilled graduate visas temporary employment visas apologies roads Italy national heritage NHMRC nutrition anti-dumping Constitutional reform referendum Rent Assistance competition policy pharmaceutical benefits scheme obesity evidence law sacrament of confession US presidential election international days DFAT UN General Assembly deregulation Regulation Impact Statements administrative law small business Breaker Morant homelessness regional engagement social determinants of health abortion Youth Allowance Members suspension citizen engagement policymaking federal election 2010 workplace health and safety Trafficking in Persons Report marine reserves hearing TAFE Victoria astronomy resources sector YMCA youth parliament alcohol Korea rebate Australian Greens presidential nomination Racial Discrimination Act entitlements political parties preselection solar hot water Financial Action Taskforce Horn of Africa peacekeeping piracy Great Barrier Reef Stronger futures political financing Hung Parliament political education social inclusion Social Inclusion Board maritime early childhood National Quality Framework for Early Childhood Education and Care Murray-Darling Basin Iran sanctions Norway hospitals republic President Barack Obama Presidential visits

Show all
Show less
Back to top